2 Sources
[1]
Zepp Health Corporation Reports Second Quarter 2024 Unaudited Financial Results - Zepp Health (NYSE:ZEPP)
MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") ZEPP today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30, 2024;
[2]
Zepp Health Corporation Reports Second Quarter 2024 Unaudited Financial Results By Investing.com
MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30,
Share
Copy Link
Zepp Health Corporation, a leading smart wearable technology company, has announced its unaudited financial results for the second quarter of 2024, showing significant revenue growth and improved profitability.

Zepp Health Corporation, a prominent player in the smart wearable technology sector, has released its unaudited financial results for the second quarter of 2024, demonstrating robust performance and market growth. The company reported a substantial increase in revenue, reaching RMB1,540.1 million (US$212.3 million), marking a 30.5% year-over-year growth
1
.The company's strategic focus on its self-branded products has paid off, with Amazfit and Zepp branded products contributing significantly to the overall revenue. These products accounted for 72.5% of total revenues, up from 66.2% in the same quarter of the previous year
2
.Zepp Health's financial results also highlight improved profitability and operational efficiency. The company reported a gross margin of 23.3%, a notable increase from 20.5% in the second quarter of 2023
1
. This improvement in gross margin reflects the company's successful efforts in optimizing its product mix and enhancing operational efficiency.Furthermore, the company achieved a net income of RMB25.4 million (US$3.5 million), a significant turnaround from a net loss of RMB45.0 million in the same period last year
2
. This positive shift in net income underscores Zepp Health's effective cost management and revenue growth strategies.Zepp Health's financial results also reflect its successful global market expansion efforts. The company reported strong performance in overseas markets, with international shipments of Amazfit and Zepp branded products increasing by 35.3% year-over-year
1
. This growth in international markets has contributed significantly to the company's overall revenue increase and demonstrates the growing global appeal of Zepp Health's smart wearable products.Related Stories
The company's commitment to product innovation continues to drive its market success. During the quarter, Zepp Health launched several new products, including the Amazfit Cheetah series and Amazfit T-Rex Ultra
2
. These new product launches have been well-received in the market, contributing to the company's revenue growth and strengthening its position in the competitive smart wearable technology sector.Looking ahead, Zepp Health remains optimistic about its future prospects. The company's management expressed confidence in maintaining this growth momentum, citing ongoing product innovation, expansion into new markets, and continued operational improvements as key drivers for future success
1
.Summarized by
Navi
[1]
27 Nov 2024•Business and Economy

14 Aug 2024

21 Aug 2024

1
Technology

2
Policy and Regulation

3
Technology
